1-8 of 8
collagen type vii
Close
Sort by
Journal Articles

Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophic Epidermolysis Bullosa

Christen L. Ebens, MD MPH, John A McGrath, MD FRCP, FMedSci, Katsuto Tamai, MD PhD, Hovnanian Alain, MD PhD, John E. Wagner, MD, Megan Riddle, Douglas R Keene, BS, Todd E. DeFor, MS, Rebecca Tryon, MS, Mei Chen, PhD, David T Woodley, MD, Kristin Hook, MD, Jakub L Tolar, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2165.
https://doi.org/10.1182/blood-2018-99-113035
Published: 2018
Journal Articles

Mucocutaneous Engraftment and Type VII Collagen (C7) Replacement after Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Jakub Tolar, MD, PhD, John A McGrath, MD, Mark J. Osborn, PhD, Douglas R Keene, BS, Kristen Hook, MD, Maria Hordinsky, MD, David Woodley, MD, Mei Chen, PhD, Alain Hovnanian, MD PhD, Katsuto Tamai, MD PhD, Bruce R. Blazar, MD, John E Wagner, MD
Journal: Blood
Blood (2015) 126 (23): 402.
https://doi.org/10.1182/blood.V126.23.402.402
Published: 2015
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Severe Epidermolysis Bullosa: Impact of Conditioning Regimen and Stem Cell Source On Outcomes

Jakub Tolar, MD, PhD, John A. McGrath, MD, FRCP, Mark J. Osborn, PhD, Kristen P. Hook, MD, Douglas R. Keene, BS, Maria K. Hordinsky, MD, Bruce R. Blazar, MD, John E. Wagner, MD
Journal: Blood
Blood (2012) 120 (21): 965.
https://doi.org/10.1182/blood.V120.21.965.965
Published: 2012
Journal Articles

Human Umbilical Cord Blood (HUCB) Derived Pluripotent Stem Cells Enhances Wound Healing

Yanling Liao, PhD, Munenari Itoh, PhD, Samantha Roberts, Alexandra M Highet, Albert Yang, Angela Christiano, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2011) 118 (21): 4824.
https://doi.org/10.1182/blood.V118.21.4824.4824
Published: 2011
Journal Articles

Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets

Michael Kasperkiewicz, Ralf Müller, Rudolf Manz, Moritz Magens, Christoph M. Hammers, Csaba Somlai, Jürgen Westermann, Enno Schmidt, Detlef Zillikens, Ralf J. Ludwig, Antal Orosz
Journal: Blood
Blood (2011) 117 (23): 6135–6142.
https://doi.org/10.1182/blood-2010-10-314609
Published: 2011
Journal Articles

First Use of Allogeneic Stem Cells in the Treatment of Recessive Dystrophic Epidermolysis Bullosa: Demonstration of Biochemical and Clinical Improvement.

John E. Wagner, MD, Akemi Ishida-Yamamoto, Ph.D., John A McGrath, Ph.D., Maria Hordinsky, M.D., Douglas R Keene, B.S., Mark Osborn, B.S., Troy Lund, MD, PhD, Michelle Dolan, Bruce R. Blazar, MD, Jakub Tolar, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 660.
https://doi.org/10.1182/blood.V114.22.660.660
Published: 2009
Journal Articles

Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells

Jakub Tolar, Akemi Ishida-Yamamoto, Megan Riddle, Ron T. McElmurry, Mark Osborn, Lily Xia, Troy Lund, Catherine Slattery, Jouni Uitto, Angela M. Christiano, John E. Wagner, Bruce R. Blazar
Journal: Blood
Blood (2009) 113 (5): 1167–1174.
https://doi.org/10.1182/blood-2008-06-161299
Published: 2009
Journal Articles

Correction of the Skin Defect in Murine Recessive Dystrophic Epidermolysis Bullosa by Bone Marrow Derived SLAM Family Receptor Enriched Cells.

Jakub Tolar, MD, PhD, Ron T. McElmurry, B.S., Hisham Bazzi, Ph.D., Lily Xia, B.S., Akemi Ishida-Yamamoto, M.D., Angela M. Christiano, M.D., Bruce R. Blazar, M.D.
Journal: Blood
Blood (2007) 110 (11): 435.
https://doi.org/10.1182/blood.V110.11.435.435
Published: 2007